Back to Explorer

Submission and Review of Sterility Information in Premarket Notification (510(k)) Submissions for Devices Labeled as Sterile: Guidance for Industry and Food and Drug Administration Staff

FinalCenter for Biologics Evaluation and Research Center for Devices and Radiological Health01/08/2024
package integrityGood Manufacturing Practice

Description

Thisguidance documentupdates and clarifies the information regarding sterilization processes that we recommend sponsors include in 510(k)s for devices labeled as sterile. This guidance document also provides details about the pyrogenicity information that we recommend sponsors include in a 510(k) submission. For the current edition of the FDA-recognized standards referenced in this document, see the FDA Recognized Consensus Standards Database Web site athttp://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfStandards/search.cfm.

Key Topics

Terms and concepts identified from this document

Scope & Applicability

Product Classes

3
Class I device

Device category that may be exempt from certain UDI requirements if GMP exempt.

Class II device

Device classification mentioned regarding novel sterilization methods

Single-use devices

Devices intended for one use only

Stakeholders

1
Sponsor

Entity responsible for submitting applications under section 524B

Regulatory Context

Regulatory Activities

3
510(k)

Premarket notification submission type

PMA

Premarket Approval Application

HDE

Humanitarian Device Exemption submissions; Humanitarian Device Exemption pathway

Document Types

2
Device Master File

contains characterization of materials

validation protocol

the validation protocol; and the sterilization validation data

Attributes

2
Pyrogenicity

Premarket Submission Recommendations including Pyrogenicity

Sterility Assurance Level

Quality parameter that must remain unchanged for the policy

Technical Details

Testing Methods

6
Bacterial Endotoxins Test

Also known as the Limulus amebocyte lysate (LAL) test

seal strength testing

associated seal strength testing, to validate package integrity

real-time aging

simulated (and/or real-time) aging and associated seal strength testing

package test methods

description of the package test methods, but not package test data

half-cycle method

the method used to validate the sterilization cycle (e.g., the half-cycle method)

simulated distribution

FDA recommends that package test methods include simulated distribution

Processes

10
Sterilization

Required for contaminated equipment and media before disposal

Ethylene oxide

Established sterilization method; Established Category A sterilization method using a fixed, rigid chamber

Vaporized hydrogen peroxide

Established sterilization method; Established Category A sterilization method

Aseptic processing

High-risk manufacturing area requiring specific gowning; Access to aseptic processing areas during inspection

Dry heat

Established Category A sterilization method

Moist heat

Example of a sterilization method.

Radiation

Established Category A sterilization method including gamma or electron beam

Ozone

Established Category B sterilization method

Vaporized peracetic acid

Novel sterilization method

Novel Sterilization Methods

information identified in Section V.A above, the sponsor should provide the following information in a 510(k) for all novel sterilization methods

Identified Hazards

Hazards

2
Infection

Risk to human health from failure to assure sterility

Material-mediated pyrogens

chemicals leaching from device causing febrile reaction

Standards & References

External Standards

4
AAMI/ANSI/ISO 11607

Packaging for terminally sterilized medical devices, series of consensus standards

USP <1050>

Viral Safety Evaluation of Biotechnology products derived from cell lines of human or animal origin

USP <161>

Medical Devices-Bacterial Endotoxin and Pyrogen Tests

ANSI/AAMI ST72

Bacterial endotoxins – Test methods, routine monitoring, and alternatives

Related CFR Sections (5)

Enforcement Impact

Deficiencies cited in Warning Letters referencing the same regulations

Adulterated under section 501(f)(1)(B)
21
Misbranded under section 502(o)
19
Failure to establish and maintain procedures to control the design of the device
10
Failure to adequately develop, maintain, and implement written MDR procedures
10
Failure to establish and maintain procedures for implementing corrective and preventive action
10
Failure to establish and maintain procedures for receiving, reviewing, and evaluating complaints
8
Unapproved Device Violations
8
Failure to establish and maintain procedures for implementing corrective and preventive actions
8
Failure to adequately establish and maintain procedures for receiving, reviewing, and evaluating complaints
8
Failure to develop, maintain, and implement written Medical Device Reporting (MDR) procedures
7

Related Warning Letters (10)

See Also (8)